HIGHLIGHTS
- who: Jesper Peter Bu00f6mers and collaborators from the Department of Clinical Experimental Research, Glostrup Research Institute, Copenhagen University Hospital-Rigshospitalet, Nordstjernevej, Glostrup, Denmark have published the article: The MEK Inhibitor Trametinib Improves Outcomes following Subarachnoid Haemorrhage in Female Rats, in the Journal: Pharmaceuticals 2022, 1446 of /2022/
- what: The initial experiments aimed to characterize the effect of OC in arteries from female rats (isolated from five rats), combined with testing three different concentrations of trametinib (0.1, 1.0, and 10 u00b5M). The authors show that there is an overall improved outcome when treating with . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.